Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medikit Co., Ltd. (7749:JPX), powered by AI.
Medikit Co., Ltd. is currently trading at ¥2,840. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Medikit Co., Ltd. on Alpha Lenz.
Medikit Co., Ltd.'s P/E ratio is 13.9.
“Medikit Co., Ltd. trades at a P/E of 13.9 (undervalued) with modest ROE of 6.8%.”
Ask for details →Medikit Co., Ltd. is a prominent player in the medical technology sector, specializing in the manufacture and development of medical and healthcare products. This company primarily focuses on the production of high-quality medical devices, such as dialysis products and blood purification devices. These critical components play a vital role in the treatment and management of chronic kidney disease, impacting healthcare providers and patients worldwide. Medikit's products are crucial in hospitals and medical facilities, ensuring effective therapeutic processes and enhancing patient care. Founded in Tokyo, Japan, Medikit has established itself as a leader in its field, leveraging advanced technologies to improve health outcomes. Its commitment to innovation and quality has solidified its reputation, making it a significant contributor to the healthcare and medical device industry. As a result, Medikit Co., Ltd. plays a crucial role in the ongoing advancement of medical technology, supporting the health and wellness of millions globally.
“Medikit Co., Ltd. trades at a P/E of 13.9 (undervalued) with modest ROE of 6.8%.”
Ask for details →Medikit Co., Ltd. (ticker: 7749) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 989 employees. Market cap is $41.8B.
The current price is 2,840 with a P/E ratio of 13.88x and P/B of 0.93x.
ROE is 6.75% and operating margin is 19.89%. Annual revenue is $22.6B.